Effect of Xiaoer Jiebiao Oral Liquid on Hand-foot-mouth Disease

• Status: Completed
• Trial end date: 2018-05-31
• Target enrollment: 0
• Participant gender: All

Summary

This is a single-blinded randomized trial aiming to evaluate the effectiveness of Xiaoer Jiebiao Oral liquid in combination with Ribavirin treatment on patients with hand-foot-mouth disease compared with the controlgroup that recieve only libavirin treatment.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Children's Hospital of Fudan University
• Collaborator: Weihai Rensheng Pharmacy
• Treatments: Ribavirin

Criteria

Inclusion Criteria:subjects should meet all of the following

• diagnosed as hand-foot-mouth disease grade I or grade II;

• body temperature at admission T>38℃，fever length<48 hours;

• no need for hormonotherapy or immunoglobulin therapy.

• signed written informed consent form

Exclusion Criteria:subjects should be excluded if meet any of the following

• with history of any heart, lung, kidney or liver diseases; under any hormonotherapy, immunoglobulin therapy or any other therapy.